Even more promising, this 2 percent increase occurred in just one year! The reason: developments in early diagnosis, says Ali Stunt, chief executive of Pancreatic Cancer Action and a pancreatic cancer survivor. The efforts and investments being made in pancreatic cancer research and early detection in the UK are commendable and the results are evident, said Julie Fleshman, JD, MBA, president and CEO of the Pancreatic Cancer Action Network (PanCAN) and chair of the World Pancreatic Cancer Coalition. Read more . . .